Ali Amad, MD, PhD

  • 6Articles
  • 55.8KReads
  • 2020–2025Active
  • 43Collaborators
  • 85Citations

About

Ali Amad, MD, PhD, is affiliated with University Lille, Inserm, CHU Lille, and the Lille Neuroscience and Cognition research unit in France. The author has published extensively on clinical topics including suicide risk and prevention, bipolar disorder, major depressive disorder, posttraumatic stress disorder, and the psychiatric impact of COVID-19. Contributions include studies on therapeutic interventions such as bright light therapy for bipolar depression and investigations into suicide reattempts and mortality. Frequent collaborators include Guillaume Vaiva, Alice Demesmaeker, Emilie Olié, Emmanuel Chazard, and Philippe Courtet.

Publications

JCP
Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder
Original Research

Bright Light Therapy in the Morning or Midday for Nonseasonal Depression in Bipolar Disorder

June 23, 2025

Bright light therapy is well tolerated in bipolar disorder, starting at 45 minutes/day, with only 6% of patients experiencing a hypomanic switch and 13% experiencing subsyndromic symptoms, which resolved...
, , , et al
JCP
PTSD and Risk of Suicide Reattempt
Original Research

PTSD and Risk of Suicide Reattempt

November 25, 2024

After controlling for comorbid psychiatric conditions and other variables, PTSD was associated with suicide reattempt at 6 months (OR= 2.33) and with rehospitalization in psychiatric settings (OR=2.24) and nonpsychiatric...
, , , et al
JCP
Mixed Features and Suicide Risk in Individuals With Major Depressive Episode
Original Research

Mixed Features and Suicide Risk in Individuals With Major Depressive Episode

November 6, 2024

In a large sample of the French population, mixed features were linked to a higher risk of suicide attempts in patients with a major depressive episode.
, , , et al
JCP
Mortality Within 1 Year After Suicide Attempt
Original Research

Mortality Within 1 Year After Suicide Attempt

September 11, 2023

One in 100 people who attempted suicide died by suicide within 1 year; men aged 45 years or older were at greater risk than other demographic groups.
, , , et al
JCP
Risk Factors for Suicide Reattempts
Original Research

Risk Factors for Suicide Reattempts

February 18, 2021

Understanding risk factors for suicidal behavior is crucial for the development of effective prevention plans. Do anxiety disorders or alcohol use disorder play a role? Learn more in this...
, , , et al
JCP
Original Research

Is COVID-19 Associated With Posttraumatic Stress Disorder?

December 8, 2020

Because COVID-19 is associated with a risk of death and lack of effective treatments, patients are at risk of developing PTSD. This cohort study assessed the prevalence of PTSD...
, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe